J01XA02 • teicoplanin • Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials
Teicoplanin is a glycopeptide antibiotic used for the treatment of severe bacterial infections caused by Gram-positive bacteria, including skin, bone, and joint infections, as well as endocarditis. It works by inhibiting bacterial cell wall synthesis, thereby destroying the bacteria.
The medication is administered via intravenous or intramuscular injection, as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the infection and the patient's response.
Patients should be monitored for potential side effects, such as injection site reactions, skin rashes, or changes in kidney function. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, skin rashes, and nausea. In rare cases, severe reactions such as kidney failure or serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Substance: teicoplanin
Date of last drug list: 01-01-2016
Commercial code: W62243002
Concentration: 200mg
Pharmaceutical form: powder + solvent for injection / infusion or oral solution
Quantity: 5
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).